Cerebellar malformation

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:182061
Who is this for?
Show terms as
1Active trials66Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Cerebellar malformation (Orphanet code 182061) is a broad category of rare congenital structural abnormalities affecting the cerebellum, the part of the brain located at the back of the skull responsible for coordinating movement, balance, posture, and motor learning. This group encompasses a wide spectrum of developmental defects ranging from complete absence of the cerebellum (cerebellar agenesis) to partial underdevelopment (cerebellar hypoplasia), abnormal foliation patterns, and other structural anomalies. Cerebellar malformations may occur in isolation or as part of more complex brain malformation syndromes. The clinical presentation varies considerably depending on the specific type and severity of the malformation. Common symptoms include motor coordination difficulties (ataxia), impaired balance, hypotonia (reduced muscle tone), delayed motor milestones, speech and language difficulties, nystagmus (involuntary eye movements), and in some cases intellectual disability or learning difficulties. Some individuals may also experience tremor, difficulties with fine motor tasks, and problems with eye movement coordination. The severity can range from mild motor clumsiness to profound neurological impairment. Cerebellar malformations can arise from a variety of causes including genetic mutations (both inherited and de novo), chromosomal abnormalities, and prenatal environmental factors such as infections or toxic exposures. The genetic basis is highly heterogeneous, with numerous genes implicated depending on the specific subtype. Diagnosis is typically made through brain magnetic resonance imaging (MRI), often supplemented by genetic testing. There is currently no curative treatment for cerebellar malformations. Management is supportive and multidisciplinary, including physical therapy, occupational therapy, speech therapy, and educational support tailored to the individual's needs. Surgical intervention may be required if associated complications such as hydrocephalus are present.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

FDA & Trial Timeline

10 events
Apr 2026Cardiac Output and Fatigue in Friedreich's Ataxia

Scott Barbuto — NA

TrialNOT YET RECRUITING
Mar 2026Interposed Nucleus aDBS for Ataxia

University of Florida — NA

TrialNOT YET RECRUITING
Mar 2026Deep Brain Stimulation for Spinocerebellar Ataxia

University of California, San Francisco — NA

TrialRECRUITING
Jan 2026Use of a New Smartphone Application to Determine Changes in Eyeblink Conditioning From Home Training in Individuals With Spinocerebellar Ataxia

Columbia University — NA

TrialNOT YET RECRUITING
Dec 2025Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-SA) for Patients With Spinocerebellar Ataxia

Sclnow Biotechnology Co., Ltd. — PHASE2

TrialNOT YET RECRUITING
Oct 2025Ophthalmological Disorders in Dominant Spinal-cerebellar Ataxias

University Hospital, Montpellier — NA

TrialRECRUITING
Jul 2025Electroencephalogram in Patients With Friedreich's Ataxia for the Study of the Structural and Functional Connectome.

IRCCS Eugenio Medea — NA

TrialRECRUITING
Jul 2025Confirmatory Study 3 of KPS-0373 in Patients With Spinocerebellar Degeneration

Kissei Pharmaceutical Co., Ltd. — PHASE3

TrialRECRUITING
Mar 2025Trial of Atezolizumab, Bevacizumab, and Tiragolumab in Patients With Microsatellite Stable, Metastatic Colorectal Cancer

University of Colorado, Denver — PHASE2

TrialACTIVE NOT RECRUITING
Feb 2025SBRT Combined With CAPEOX, Bevacizumab, and PD-1 Inhibitor for the Treatment of RAS-Mutant, MSS-Type, Unresectable Metastatic Colorectal Cancer.

The First Affiliated Hospital with Nanjing Medical University — PHASE2

TrialNOT YET RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Cerebellar malformation.

1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

1 recruitingView all trials with filters →
N/A1 trial
Spatiotemporal Entrainment Neuromodulation Targeting Cerebello-Cerebral Circuits to Enhance Cognitive and Social Rehabilitation in Cerebellar Diseases
N/A
Actively Recruiting
PI: Maria Leggio, MD, PhD (I.R.C.C.S. Fondazione Santa Lucia) · Sites: Pavia; Roma · Age: 1299 yrs

Specialists

Showing 25 of 66View all specialists →
PK
Pawan Kumar
BINGHAMTON, NY
Specialist
1 Cerebellar malformation publication
AC
Aditya Chadda
Specialist
1 Cerebellar malformation publication
NS
Naveen Sankhyan
Specialist
1 Cerebellar malformation publication
BD
B Divya
Specialist
1 Cerebellar malformation publication
QG
Qianqian Gao
Specialist
1 Cerebellar malformation publication
SL
Shanling Liu
Specialist
1 Cerebellar malformation publication
QZ
Qianying Zhao
Specialist
1 Cerebellar malformation publication
QX
Qinqin Xiang
Specialist
1 Cerebellar malformation publication
BX
Bocheng Xu
Specialist
1 Cerebellar malformation publication
LW
Lingyi Wen
Specialist
1 Cerebellar malformation publication
YT
Yu Tan
Specialist
1 Cerebellar malformation publication
MY
Mei Yang
Specialist
1 Cerebellar malformation publication
HX
Hanbing Xie
Specialist
1 Cerebellar malformation publication
PM
Priyanka Madaan
Specialist
1 Cerebellar malformation publication
HW
He Wang
Specialist
1 Cerebellar malformation publication
RM
Ronald G Crystal, MD
NEW YORK, NY
Specialist
PI on 12 active trials
LM
Laurent Servais, MD
Specialist
PI on 6 active trials1 Cerebellar malformation publication
PM
Peter Milner, MD
LOS ALTOS HILLS, CA
Specialist
PI on 4 active trials
TM
Thomas Klopstock, MD
Specialist
PI on 4 active trials
AD
Alexandra DURR
EAGAN, MN
Specialist
PI on 2 active trials
MM
Magdy Shenouda, M.D.
WALL, NJ
Specialist
PI on 3 active trials
DP
David Lynch, MD, PhD
Specialist
PI on 4 active trials
KP
Kon Chu, MD, PhD
Specialist
PI on 3 active trials
AM
Alessandro Filla, MD
Specialist
PI on 3 active trials1 Cerebellar malformation publication

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Cerebellar malformation.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Cerebellar malformationForum →

No community posts yet. Be the first to share your experience with Cerebellar malformation.

Start the conversation →

Latest news about Cerebellar malformation

Disease timeline:

New recruiting trial: A Study to Learn More About the Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Who Are Prescribed it by Their Own Doctors

A new clinical trial is recruiting patients for Cerebellar malformation

New recruiting trial: Efficacy of Stabilometric Platform to Improve Standing Balance in Patients With Friedreich's Ataxia

A new clinical trial is recruiting patients for Cerebellar malformation

New recruiting trial: Ophthalmological Disorders in Dominant Spinal-cerebellar Ataxias

A new clinical trial is recruiting patients for Cerebellar malformation

New recruiting trial: Effects of Oral Administration of Antrodia Cinnamomea Products for Clinical Symptoms in Spinocerebellar Ataxia Patients

A new clinical trial is recruiting patients for Cerebellar malformation

New recruiting trial: Characterisation of the Cognitive Profile of Patients Suffering From Friedreich's Ataxia

A new clinical trial is recruiting patients for Cerebellar malformation

New recruiting trial: Cycling-Based Priming Coordination Training for Enhancing Ataxia Recovery and Brain Plasticity

A new clinical trial is recruiting patients for Cerebellar malformation

New recruiting trial: The EUROSCA Natural History Study

A new clinical trial is recruiting patients for Cerebellar malformation

New recruiting trial: Study of ARO-ATXN2 Injection in Adults With Spinocerebellar Ataxia Type 2

A new clinical trial is recruiting patients for Cerebellar malformation

New recruiting trial: Electroencephalogram in Patients With Friedreich's Ataxia for the Study of the Structural and Functional Connectome.

A new clinical trial is recruiting patients for Cerebellar malformation

New recruiting trial: A Multiple Ascending Dose Study of DT-216P2 in Patients With Friedreich's Ataxia

A new clinical trial is recruiting patients for Cerebellar malformation

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Cerebellar malformation

What is Cerebellar malformation?

Cerebellar malformation (Orphanet code 182061) is a broad category of rare congenital structural abnormalities affecting the cerebellum, the part of the brain located at the back of the skull responsible for coordinating movement, balance, posture, and motor learning. This group encompasses a wide spectrum of developmental defects ranging from complete absence of the cerebellum (cerebellar agenesis) to partial underdevelopment (cerebellar hypoplasia), abnormal foliation patterns, and other structural anomalies. Cerebellar malformations may occur in isolation or as part of more complex brain ma

At what age does Cerebellar malformation typically begin?

Typical onset of Cerebellar malformation is neonatal. Age of onset can vary across affected individuals.

Are there clinical trials for Cerebellar malformation?

Yes — 1 recruiting clinical trial is currently listed for Cerebellar malformation on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Cerebellar malformation?

25 specialists and care centers treating Cerebellar malformation are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.